184 related articles for article (PubMed ID: 16907895)
1. Clinical outcome in upper gastrointestinal bleeding complicating low-dose aspirin and antithrombotic drugs.
Taha AS; Angerson WJ; Knill-Jones RP; Blatchford O
Aliment Pharmacol Ther; 2006 Aug; 24(4):633-6. PubMed ID: 16907895
[TBL] [Abstract][Full Text] [Related]
2. Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy.
Taha AS; Angerson WJ; Knill-Jones RP; Blatchford O
Aliment Pharmacol Ther; 2006 Feb; 23(4):489-95. PubMed ID: 16441469
[TBL] [Abstract][Full Text] [Related]
3. Upper gastrointestinal haemorrhage associated with low-dose aspirin and anti-thrombotic drugs - a 6-year analysis and comparison with non-steroidal anti-inflammatory drugs.
Taha AS; Angerson WJ; Knill-Jones RP; Blatchford O
Aliment Pharmacol Ther; 2005 Aug; 22(4):285-9. PubMed ID: 16097994
[TBL] [Abstract][Full Text] [Related]
4. A case-control study of the association between polymorphisms of the endothelial nitric oxide synthase and glycoprotein IIIa genes and upper gastrointestinal bleeding in users of low-dose aspirin.
Piazuelo E; Fuentes J; García-González MA; Jiménez P; Lanas A
Clin Ther; 2008 Jan; 30(1):121-30. PubMed ID: 18343248
[TBL] [Abstract][Full Text] [Related]
5. Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin.
Sørensen HT; Mellemkjaer L; Blot WJ; Nielsen GL; Steffensen FH; McLaughlin JK; Olsen JH
Am J Gastroenterol; 2000 Sep; 95(9):2218-24. PubMed ID: 11007221
[TBL] [Abstract][Full Text] [Related]
6. Do nonsteroidal anti-inflammatory drugs affect the outcome of patients admitted to hospital with lower gastrointestinal bleeding?
Yong D; Grieve P; Keating J
N Z Med J; 2003 Jul; 116(1178):U517. PubMed ID: 12897885
[TBL] [Abstract][Full Text] [Related]
7. Hospitalization for gastrointestinal adverse events attributable to the use of low-dose aspirin among patients 50 years or older also using non-steroidal anti-inflammatory drugs: a retrospective cohort study.
Rahme E; Nedjar H; Bizzi A; Morin S
Aliment Pharmacol Ther; 2007 Nov; 26(10):1387-98. PubMed ID: 17892525
[TBL] [Abstract][Full Text] [Related]
8. [Risk and prevention of gastrointestinal complications due to low-dose aspirin and other antiplatelet agents].
Bretagne JF
Rev Prat; 2008 Sep; 58(13):1434-6, 1439-40. PubMed ID: 18924327
[TBL] [Abstract][Full Text] [Related]
9. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study.
Hallas J; Dall M; Andries A; Andersen BS; Aalykke C; Hansen JM; Andersen M; Lassen AT
BMJ; 2006 Oct; 333(7571):726. PubMed ID: 16984924
[TBL] [Abstract][Full Text] [Related]
10. Colonic diverticular hemorrhage associated with the use of nonsteroidal anti-inflammatory drugs, low-dose aspirin, antiplatelet drugs, and dual therapy.
Nagata N; Niikura R; Aoki T; Shimbo T; Kishida Y; Sekine K; Tanaka S; Watanabe K; Sakurai T; Yokoi C; Akiyama J; Yanase M; Mizokami M; Uemura N
J Gastroenterol Hepatol; 2014 Oct; 29(10):1786-93. PubMed ID: 24720424
[TBL] [Abstract][Full Text] [Related]
11. Upper gastrointestinal bleeding and the changing use of COX-2 non-steroidal anti-inflammatory drugs and low-dose aspirin.
Taha AS; Angerson WJ; Prasad R; McCloskey C; Blatchford O
Aliment Pharmacol Ther; 2007 Oct; 26(8):1171-8. PubMed ID: 17894659
[TBL] [Abstract][Full Text] [Related]
12. [Upper gastrointestinal bleeding in patients treated by low-dose aspirin].
Capet C; Czernichow P; Dupas JL; Goria O; Gouérou H; Hochain P; Amouretti M; Herman H; Colin R
Gastroenterol Clin Biol; 2001 Mar; 25(3):233-8. PubMed ID: 11395668
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet agents do not impact the hospital course in patients with gastrointestinal bleeding.
John BK; Arramraju S; Shalomov A; Sison C; Rubin M
J Clin Gastroenterol; 2011 Aug; 45(7):583-9. PubMed ID: 21293292
[TBL] [Abstract][Full Text] [Related]
14. Thirty-day mortality after peptic ulcer bleeding in hospitalized patients receiving low-dose aspirin at time of admission.
Mose H; Larsen M; Riis A; Johnsen SP; Thomsen RW; Sørensen HT
Am J Geriatr Pharmacother; 2006 Sep; 4(3):244-50. PubMed ID: 17062325
[TBL] [Abstract][Full Text] [Related]
15. Strategies to reduce the GI risks of antiplatelet therapy.
Scheiman JM
Rev Cardiovasc Med; 2005; 6 Suppl 4():S23-31. PubMed ID: 17710073
[TBL] [Abstract][Full Text] [Related]
16. Upper GI risks of NSAIDs and antiplatelet agents: key issues for the cardiologist.
Johnson DA
Rev Cardiovasc Med; 2005; 6 Suppl 4():S15-22. PubMed ID: 17710072
[TBL] [Abstract][Full Text] [Related]
17. Risk scoring systems to predict need for clinical intervention for patients with nonvariceal upper gastrointestinal tract bleeding.
Chen IC; Hung MS; Chiu TF; Chen JC; Hsiao CT
Am J Emerg Med; 2007 Sep; 25(7):774-9. PubMed ID: 17870480
[TBL] [Abstract][Full Text] [Related]
18. [Significance of the stool occult blood test in patients with thrombotic disease under treatment with low dose aspirin].
Hayashi S; Wakizaka A
Rinsho Ketsueki; 2005 Apr; 46(4):254-60. PubMed ID: 16444957
[TBL] [Abstract][Full Text] [Related]
19. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
Hermann A; Dzialowski I; Koch R; Gahn G
J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
[TBL] [Abstract][Full Text] [Related]
20. Management of upper gastrointestinal haemorrhage complicating dual anti-platelet therapy.
Henriksen PA; Palmer K; Boon NA
QJM; 2008 Apr; 101(4):261-7. PubMed ID: 18252776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
